Representative image
CHENNAI: The Indian Council of Medical Research (ICMR) is sitting on a proposal for a clinical trial of an affordable and time-tested anti-inflammatory arthritis drug that has the potential to prevent thousands of deaths due to Covid-19.
Indomethacin has been used to prevent cytokine storm – an abnormal immune reaction that kills Covid-19 patients – in people with other health conditions. The drug costs Rs 5 a capsule, while Tocilizumab, a drug now used to treat cytokine storm, costs Rs 60,000 per dose.
C hennai-based kidney trans